Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia

Fig. 3

Slope of FVC % predicted for 2 years after SLB. BAL bronchoalveolar lavage, FVC forced vital capacity, SLB surgical lung biopsy. For patients treated with anti-inflammatory drugs, patients with BAL lymphocytosis show a higher slope of FVC % predicted than patients without BAL lymphocytosis (a). On the other hand, limited to patients without anti-inflammatory drugs, no difference is evident between the groups (b)

Back to article page